跳至主要内容
临床试验/EUCTR2012-005374-57-SE
EUCTR2012-005374-57-SE进行中(未招募)1 期

Primary hyperparathyroidism: Short-term calcimimetics treatment – Relevance for parathyroid surgery decisions?

Department of Breast and Endocrine Surgery, Karolinska University Hospital0 个研究点目标入组 100 人开始时间: 2012年12月18日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • Primary hyperparathyroidism, scheduled for parathyroid surgery
  • Woman (part A only)
  • Understand the purpose of the study, able to participate in all tests included in the study model
  • Signed informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 100
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Breast feeding
  • Fertile woman not using contraceptives
  • Impaired kidney function, GFR < 40 ml/min
  • Intolerance to Mimpara
  • Previously treated with Mimpara
  • Participating in other ongoing clinical study

研究者

发起方
Department of Breast and Endocrine Surgery, Karolinska University Hospital

相似试验

已完成
不适用
Primary Hyperparathyroidism: Short-term Calcimimetics Treatment - Relevance for Parathyroid Surgery Decisions?Primary Hyperparathyroidism
NCT02227264Karolinska University Hospital110
已完成
不适用
Recurrent/persistent primary hyperparathyroidism, clinical, pathological and genetic aspectshyperactive parathyroid glands10033949primary hyperparathyroidism
NL-OMON32114eids Universitair Medisch Centrum30
进行中(未招募)
1 期
Primary hyperparathyroidism: does a systematic treatment improve the calcium and bone metabolism after successful surgery? – Part IISystematic treatment of patients with neither osteopenia nor osteoporosis after successful surgical treatment for primary hyperparathyroidism with Calcium and Vitamin DHypothesis: Calcium and vitamin D intake after surgery for PHPT protects the bone by keeping PTH in the normal range (less secondary, reactive hyperparathyroidism), prevents hungry bone- syndrome and improve bone-turnover markers (osteoporosis protection).MedDRA version: 9.1Level: LLTClassification code 10020707Term: Hyperparathyroidism primary
EUCTR2008-001704-23-ATMedizinische Universität Wien, Universitätsklinik für Chirurgie80
进行中(未招募)
1 期
Primary hyperparathyroidism: does a systematic treatment improve the calcium- and bone metabolism after successful surgery? – Part Systematic treatment of osteopenic and osteoporotic postmenopausal patients after successful surgical treatment for primary hyperparathyroidism with Strontium ranelateOsteopenia or Osteoporosis in postmenopausal womenPrimary hyperparathyroidismMedDRA version: 9.1Level: LLTClassification code 10020707Term: Hyperparathyroidism primaryMedDRA version: 9.1Level: PTClassification code 10031285Term: Osteoporosis postmenopausal
EUCTR2008-001703-32-ATMedical University of Vienna60
已完成
不适用
Burden of Illness in HypoparathyroidismHypoparathyroidism
NCT03437174University of Wuerzburg205